Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 339 entries
Sorted by: Best Match Show Resources per page
Higher discontinuation and lower survival rates are likely in elderly Japanese patients with advanced hepatocellular carcinoma receiving sorafenib.

Hepatology research : the official journal of the Japan Society of Hepatology

Morimoto M, Numata K, Kondo M, Hidaka H, Takada J, Shibuya A, Kobayashi S, Ohkawa S, Okuse C, Morita S, Taguri M, Tanaka K.
PMID: 21348907
Hepatol Res. 2011 Apr;41(4):296-302. doi: 10.1111/j.1872-034X.2011.00778.x. Epub 2011 Feb 23.

AIM:   Sorafenib is approved for the treatment of advanced hepatocellular carcinoma (HCC) in Japan; however, its tolerability and efficacy in elderly patients with HCC have not been clarified. We aimed to evaluate the tolerability and efficacy of sorafenib with...

Cite
Morimoto M, Numata K, Kondo M, et al. Higher discontinuation and lower survival rates are likely in elderly Japanese patients with advanced hepatocellular carcinoma receiving sorafenib. Hepatol Res. 2011;41(4):296-302doi: 10.1111/j.1872-034X.2011.00778.x.
Morimoto, M., Numata, K., Kondo, M., Hidaka, H., Takada, J., Shibuya, A., Kobayashi, S., Ohkawa, S., Okuse, C., Morita, S., Taguri, M., & Tanaka, K. (2011). Higher discontinuation and lower survival rates are likely in elderly Japanese patients with advanced hepatocellular carcinoma receiving sorafenib. Hepatology research : the official journal of the Japan Society of Hepatology, 41(4), 296-302. https://doi.org/10.1111/j.1872-034X.2011.00778.x
Morimoto, Manabu, et al. "Higher discontinuation and lower survival rates are likely in elderly Japanese patients with advanced hepatocellular carcinoma receiving sorafenib." Hepatology research : the official journal of the Japan Society of Hepatology vol. 41,4 (2011): 296-302. doi: https://doi.org/10.1111/j.1872-034X.2011.00778.x
Morimoto M, Numata K, Kondo M, Hidaka H, Takada J, Shibuya A, Kobayashi S, Ohkawa S, Okuse C, Morita S, Taguri M, Tanaka K. Higher discontinuation and lower survival rates are likely in elderly Japanese patients with advanced hepatocellular carcinoma receiving sorafenib. Hepatol Res. 2011 Apr;41(4):296-302. doi: 10.1111/j.1872-034X.2011.00778.x. Epub 2011 Feb 23. PMID: 21348907.
Copy Download .nbib Format: NLM
Corrigendum to "Aminophylline increases respiratory muscle activity during hypercapnia in humans" [Pulm. Pharmacol. Ther. (2015) 96-101].

Pulmonary pharmacology & therapeutics

Yokoba M, Ichikawa T, Takakura A, Ishii N, Kurosaki Y, Yamada Y, Tsukushi T, Masuda N, Easton PA, Katagiri M.
PMID: 27692698
Pulm Pharmacol Ther. 2016 Dec;41:103. doi: 10.1016/j.pupt.2016.09.009. Epub 2016 Sep 28.

No abstract available.

Cite
Yokoba M, Ichikawa T, Takakura A, et al. Corrigendum to "Aminophylline increases respiratory muscle activity during hypercapnia in humans" [Pulm. Pharmacol. Ther. (2015) 96-101]. Pulm Pharmacol Ther. 2016;41:103doi: 10.1016/j.pupt.2016.09.009.
Yokoba, M., Ichikawa, T., Takakura, A., Ishii, N., Kurosaki, Y., Yamada, Y., Tsukushi, T., Masuda, N., Easton, P. A., & Katagiri, M. (2016). Corrigendum to "Aminophylline increases respiratory muscle activity during hypercapnia in humans" [Pulm. Pharmacol. Ther. (2015) 96-101]. Pulmonary pharmacology & therapeutics, 41103. https://doi.org/10.1016/j.pupt.2016.09.009
Yokoba, Masanori, et al. "Corrigendum to "Aminophylline increases respiratory muscle activity during hypercapnia in humans" [Pulm. Pharmacol. Ther. (2015) 96-101]." Pulmonary pharmacology & therapeutics vol. 41 (2016): 103. doi: https://doi.org/10.1016/j.pupt.2016.09.009
Yokoba M, Ichikawa T, Takakura A, Ishii N, Kurosaki Y, Yamada Y, Tsukushi T, Masuda N, Easton PA, Katagiri M. Corrigendum to "Aminophylline increases respiratory muscle activity during hypercapnia in humans" [Pulm. Pharmacol. Ther. (2015) 96-101]. Pulm Pharmacol Ther. 2016 Dec;41:103. doi: 10.1016/j.pupt.2016.09.009. Epub 2016 Sep 28. PMID: 27692698.
Copy Download .nbib Format: NLM
Continuous positive airway pressure oxygenation during one-lung ventilation with 50% nitrous oxide and isoflurane in oxygen.

Journal of anesthesia

Taneyama C, Fujita T, Kohno N, Otagiri T, Goto H.
PMID: 28921233
J Anesth. 1995 Sep;9(3):285-288. doi: 10.1007/BF02479880.

No abstract available.

Cite
Taneyama C, Fujita T, Kohno N, et al. Continuous positive airway pressure oxygenation during one-lung ventilation with 50% nitrous oxide and isoflurane in oxygen. J Anesth. 1995;9(3):285-288doi: 10.1007/BF02479880.
Taneyama, C., Fujita, T., Kohno, N., Otagiri, T., & Goto, H. (1995). Continuous positive airway pressure oxygenation during one-lung ventilation with 50% nitrous oxide and isoflurane in oxygen. Journal of anesthesia, 9(3), 285-288. https://doi.org/10.1007/BF02479880
Taneyama, Chikuni, et al. "Continuous positive airway pressure oxygenation during one-lung ventilation with 50% nitrous oxide and isoflurane in oxygen." Journal of anesthesia vol. 9,3 (1995): 285-288. doi: https://doi.org/10.1007/BF02479880
Taneyama C, Fujita T, Kohno N, Otagiri T, Goto H. Continuous positive airway pressure oxygenation during one-lung ventilation with 50% nitrous oxide and isoflurane in oxygen. J Anesth. 1995 Sep;9(3):285-288. doi: 10.1007/BF02479880. PMID: 28921233.
Copy Download .nbib Format: NLM
Comments on 'A cautionary note concerning the use of stabilized weights in marginal structural models' by D. Talbot, J. Atherton, A. M. Rossi, S. L. Bacon, and G. Lefebvre.

Statistics in medicine

Taguri M.
PMID: 25755017
Stat Med. 2015 Apr 15;34(8):1438-9. doi: 10.1002/sim.6422.

No abstract available.

Cite
Taguri M. Comments on 'A cautionary note concerning the use of stabilized weights in marginal structural models' by D. Talbot, J. Atherton, A. M. Rossi, S. L. Bacon, and G. Lefebvre. Stat Med. 2015;34(8):1438-9doi: 10.1002/sim.6422.
Taguri, M. (2015). Comments on 'A cautionary note concerning the use of stabilized weights in marginal structural models' by D. Talbot, J. Atherton, A. M. Rossi, S. L. Bacon, and G. Lefebvre. Statistics in medicine, 34(8), 1438-9. https://doi.org/10.1002/sim.6422
Taguri, Masataka. "Comments on 'A cautionary note concerning the use of stabilized weights in marginal structural models' by D. Talbot, J. Atherton, A. M. Rossi, S. L. Bacon, and G. Lefebvre." Statistics in medicine vol. 34,8 (2015): 1438-9. doi: https://doi.org/10.1002/sim.6422
Taguri M. Comments on 'A cautionary note concerning the use of stabilized weights in marginal structural models' by D. Talbot, J. Atherton, A. M. Rossi, S. L. Bacon, and G. Lefebvre. Stat Med. 2015 Apr 15;34(8):1438-9. doi: 10.1002/sim.6422. PMID: 25755017.
Copy Download .nbib Format: NLM
Successful treatment with s-1 and oxaliplatin combination therapy in an elderly patient with metastatic colorectal cancer initially presenting with membranous nephropathy.

Case reports in oncology

Matsunaga M, Miwa K, Oka Y, Ushijima T, Yuge K, Fukahori M, Katagiri M, Akagi Y.
PMID: 26034482
Case Rep Oncol. 2015 Apr 28;8(1):212-6. doi: 10.1159/000382119. eCollection 2015.

The incidence, morbidity, and mortality of colorectal cancer are increasing, largely owing to an increasingly aging population. Additionally, along with the increasing age of cancer patients, the number of patients with various comorbidities such as membranous nephropathy is also...

Cite
Matsunaga M, Miwa K, Oka Y, et al. Successful treatment with s-1 and oxaliplatin combination therapy in an elderly patient with metastatic colorectal cancer initially presenting with membranous nephropathy. Case Rep Oncol. 2015;8(1):212-6doi: 10.1159/000382119.
Matsunaga, M., Miwa, K., Oka, Y., Ushijima, T., Yuge, K., Fukahori, M., Katagiri, M., & Akagi, Y. (2015). Successful treatment with s-1 and oxaliplatin combination therapy in an elderly patient with metastatic colorectal cancer initially presenting with membranous nephropathy. Case reports in oncology, 8(1), 212-6. https://doi.org/10.1159/000382119
Matsunaga, Mototsugu, et al. "Successful treatment with s-1 and oxaliplatin combination therapy in an elderly patient with metastatic colorectal cancer initially presenting with membranous nephropathy." Case reports in oncology vol. 8,1 (2015): 212-6. doi: https://doi.org/10.1159/000382119
Matsunaga M, Miwa K, Oka Y, Ushijima T, Yuge K, Fukahori M, Katagiri M, Akagi Y. Successful treatment with s-1 and oxaliplatin combination therapy in an elderly patient with metastatic colorectal cancer initially presenting with membranous nephropathy. Case Rep Oncol. 2015 Apr 28;8(1):212-6. doi: 10.1159/000382119. eCollection 2015. PMID: 26034482; PMCID: PMC4448055.
Copy Download .nbib Format: NLM
A proposal of clinical ECG index "vagal score" for determining the mechanism of paroxysmal atrioventricular block.

Journal of arrhythmia

Komatsu S, Sumiyoshi M, Miura S, Kimura Y, Shiozawa T, Hirano K, Odagiri F, Tabuchi H, Hayashi H, Sekita G, Tokano T, Nakazato Y, Daida H.
PMID: 28607616
J Arrhythm. 2017 Jun;33(3):208-213. doi: 10.1016/j.joa.2016.10.004. Epub 2016 Nov 09.

BACKGROUND: Paroxysmal atrioventricular block (P-AVB) is a well-known cause of syncope; however, its underlying mechanism is difficult to determine. This study aimed to evaluate a new ECG index, the "vagal score (VS)," to determine the mechanism of P-AVB.METHODS: We...

Cite
Komatsu S, Sumiyoshi M, Miura S, et al. A proposal of clinical ECG index "vagal score" for determining the mechanism of paroxysmal atrioventricular block. J Arrhythm. 2016;33(3):208-213doi: 10.1016/j.joa.2016.10.004.
Komatsu, S., Sumiyoshi, M., Miura, S., Kimura, Y., Shiozawa, T., Hirano, K., Odagiri, F., Tabuchi, H., Hayashi, H., Sekita, G., Tokano, T., Nakazato, Y., & Daida, H. (2017). A proposal of clinical ECG index "vagal score" for determining the mechanism of paroxysmal atrioventricular block. Journal of arrhythmia, 33(3), 208-213. https://doi.org/10.1016/j.joa.2016.10.004
Komatsu, Sayaka, et al. "A proposal of clinical ECG index "vagal score" for determining the mechanism of paroxysmal atrioventricular block." Journal of arrhythmia vol. 33,3 (2017): 208-213. doi: https://doi.org/10.1016/j.joa.2016.10.004
Komatsu S, Sumiyoshi M, Miura S, Kimura Y, Shiozawa T, Hirano K, Odagiri F, Tabuchi H, Hayashi H, Sekita G, Tokano T, Nakazato Y, Daida H. A proposal of clinical ECG index "vagal score" for determining the mechanism of paroxysmal atrioventricular block. J Arrhythm. 2017 Jun;33(3):208-213. doi: 10.1016/j.joa.2016.10.004. Epub 2016 Nov 09. PMID: 28607616; PMCID: PMC5459424.
Copy Download .nbib Format: NLM
Efficient inhibition of tumor angiogenesis and growth by a synthetic peptide blocking S100A4-methionine aminopeptidase 2 interaction.

Molecular therapy. Methods & clinical development

Ochiya T, Takenaga K, Asagiri M, Nakano K, Satoh H, Watanabe T, Imajoh-Ohmi S, Endo H.
PMID: 26029719
Mol Ther Methods Clin Dev. 2015 Apr 01;2:15008. doi: 10.1038/mtm.2015.8. eCollection 2015.

The prometastatic calcium-binding protein, S100A4, is expressed in endothelial cells, and its downregulation markedly suppresses tumor angiogenesis in a xenograft cancer model. Given that endothelial S100A4 can be a molecular target for inhibiting tumor angiogenesis, we addressed here whether...

Cite
Ochiya T, Takenaga K, Asagiri M, et al. Efficient inhibition of tumor angiogenesis and growth by a synthetic peptide blocking S100A4-methionine aminopeptidase 2 interaction. Mol Ther Methods Clin Dev. 2015;2:15008doi: 10.1038/mtm.2015.8.
Ochiya, T., Takenaga, K., Asagiri, M., Nakano, K., Satoh, H., Watanabe, T., Imajoh-Ohmi, S., & Endo, H. (2015). Efficient inhibition of tumor angiogenesis and growth by a synthetic peptide blocking S100A4-methionine aminopeptidase 2 interaction. Molecular therapy. Methods & clinical development, 215008. https://doi.org/10.1038/mtm.2015.8
Ochiya, Takahiro, et al. "Efficient inhibition of tumor angiogenesis and growth by a synthetic peptide blocking S100A4-methionine aminopeptidase 2 interaction." Molecular therapy. Methods & clinical development vol. 2 (2015): 15008. doi: https://doi.org/10.1038/mtm.2015.8
Ochiya T, Takenaga K, Asagiri M, Nakano K, Satoh H, Watanabe T, Imajoh-Ohmi S, Endo H. Efficient inhibition of tumor angiogenesis and growth by a synthetic peptide blocking S100A4-methionine aminopeptidase 2 interaction. Mol Ther Methods Clin Dev. 2015 Apr 01;2:15008. doi: 10.1038/mtm.2015.8. eCollection 2015. PMID: 26029719; PMCID: PMC4445002.
Copy Download .nbib Format: NLM
Coil-globule transition of a polymer involved in excluded-volume interactions with macromolecules.

The Journal of chemical physics

Odagiri K, Seki K.
PMID: 26450330
J Chem Phys. 2015 Oct 07;143(13):134903. doi: 10.1063/1.4932344.

Polymers adopt extended coil and compact globule states according to the balance between entropy and interaction energies. The transition of a polymer between an extended coil state and compact globule state can be induced by changing thermodynamic force such...

Cite
Odagiri K, Seki K. Coil-globule transition of a polymer involved in excluded-volume interactions with macromolecules. J Chem Phys. 2015;143(13):134903doi: 10.1063/1.4932344.
Odagiri, K., & Seki, K. (2015). Coil-globule transition of a polymer involved in excluded-volume interactions with macromolecules. The Journal of chemical physics, 143(13), 134903. https://doi.org/10.1063/1.4932344
Odagiri, Kenta, and Seki, Kazuhiko. "Coil-globule transition of a polymer involved in excluded-volume interactions with macromolecules." The Journal of chemical physics vol. 143,13 (2015): 134903. doi: https://doi.org/10.1063/1.4932344
Odagiri K, Seki K. Coil-globule transition of a polymer involved in excluded-volume interactions with macromolecules. J Chem Phys. 2015 Oct 07;143(13):134903. doi: 10.1063/1.4932344. PMID: 26450330.
Copy Download .nbib Format: NLM
The kinetics of salicylate hydroxylase reaction.

FEBS letters

Takemori S, Nakamura M, Suzuki K, Katagiri M, Nakamura T.
PMID: 11947401
FEBS Lett. 1970 Feb 25;6(4):305-308. doi: 10.1016/0014-5793(70)80084-9.

No abstract available.

Cite
Takemori S, Nakamura M, Suzuki K, et al. The kinetics of salicylate hydroxylase reaction. FEBS Lett. 1970;6(4):305-308doi: 10.1016/0014-5793(70)80084-9.
Takemori, S., Nakamura, M., Suzuki, K., Katagiri, M., & Nakamura, T. (1970). The kinetics of salicylate hydroxylase reaction. FEBS letters, 6(4), 305-308. https://doi.org/10.1016/0014-5793(70)80084-9
Takemori, S, et al. "The kinetics of salicylate hydroxylase reaction." FEBS letters vol. 6,4 (1970): 305-308. doi: https://doi.org/10.1016/0014-5793(70)80084-9
Takemori S, Nakamura M, Suzuki K, Katagiri M, Nakamura T. The kinetics of salicylate hydroxylase reaction. FEBS Lett. 1970 Feb 25;6(4):305-308. doi: 10.1016/0014-5793(70)80084-9. PMID: 11947401.
Copy Download .nbib Format: NLM
Spectral characteristics of lactate oxygenase in aerobic and anaerobic reactions.

FEBS letters

Takemori S, Nakai Y, Katagiri M, Nakamura T.
PMID: 11947011
FEBS Lett. 1969 May;3(3):214-216. doi: 10.1016/0014-5793(69)80139-0.

No abstract available.

Cite
Takemori S, Nakai Y, Katagiri M, et al. Spectral characteristics of lactate oxygenase in aerobic and anaerobic reactions. FEBS Lett. 1969;3(3):214-216doi: 10.1016/0014-5793(69)80139-0.
Takemori, S., Nakai, Y., Katagiri, M., & Nakamura, T. (1969). Spectral characteristics of lactate oxygenase in aerobic and anaerobic reactions. FEBS letters, 3(3), 214-216. https://doi.org/10.1016/0014-5793(69)80139-0
Takemori, S, et al. "Spectral characteristics of lactate oxygenase in aerobic and anaerobic reactions." FEBS letters vol. 3,3 (1969): 214-216. doi: https://doi.org/10.1016/0014-5793(69)80139-0
Takemori S, Nakai Y, Katagiri M, Nakamura T. Spectral characteristics of lactate oxygenase in aerobic and anaerobic reactions. FEBS Lett. 1969 May;3(3):214-216. doi: 10.1016/0014-5793(69)80139-0. PMID: 11947011.
Copy Download .nbib Format: NLM
Oxygenation: a specific soluble cytochrome p-450 coupled enzyme complex.

Science (New York, N.Y.)

Gunsalus IC, Ganguli BN, Katagiri M, Tsibris JC, Debrunner P, Frauenfelder H.
PMID: 17740237
Science. 1968 Apr 26;160(3826):438-9. doi: 10.1126/science.160.3826.438-c.

No abstract available.

Cite
Gunsalus IC, Ganguli BN, Katagiri M, et al. Oxygenation: a specific soluble cytochrome p-450 coupled enzyme complex. Science. 1968;160(3826):438-9doi: 10.1126/science.160.3826.438-c.
Gunsalus, I. C., Ganguli, B. N., Katagiri, M., Tsibris, J. C., Debrunner, P., & Frauenfelder, H. (1968). Oxygenation: a specific soluble cytochrome p-450 coupled enzyme complex. Science (New York, N.Y.), 160(3826), 438-9. https://doi.org/10.1126/science.160.3826.438-c
Gunsalus, I C, et al. "Oxygenation: a specific soluble cytochrome p-450 coupled enzyme complex." Science (New York, N.Y.) vol. 160,3826 (1968): 438-9. doi: https://doi.org/10.1126/science.160.3826.438-c
Gunsalus IC, Ganguli BN, Katagiri M, Tsibris JC, Debrunner P, Frauenfelder H. Oxygenation: a specific soluble cytochrome p-450 coupled enzyme complex. Science. 1968 Apr 26;160(3826):438-9. doi: 10.1126/science.160.3826.438-c. PMID: 17740237.
Copy Download .nbib Format: NLM
Sugar-sensitive thin films composed of concanavalin A and glycogen.

Analytical sciences : the international journal of the Japan Society for Analytical Chemistry

Sato K, Imoto Y, Sugama J, Seki S, Inoue H, Odagiri T, Anzai J.
PMID: 15478330
Anal Sci. 2004 Sep;20(9):1247-8. doi: 10.2116/analsci.20.1247.

Sugar-sensitive thin films were prepared by a layer-by-layer deposition of concanavalin A (Con A) and glycogen on the surface of a quartz slide and their sugar-induced decomposition was studied. The Con A/glycogen multilayer films can be decomposed by exposing...

Cite
Sato K, Imoto Y, Sugama J, et al. Sugar-sensitive thin films composed of concanavalin A and glycogen. Anal Sci. 2004;20(9):1247-8doi: 10.2116/analsci.20.1247.
Sato, K., Imoto, Y., Sugama, J., Seki, S., Inoue, H., Odagiri, T., & Anzai, J. (2004). Sugar-sensitive thin films composed of concanavalin A and glycogen. Analytical sciences : the international journal of the Japan Society for Analytical Chemistry, 20(9), 1247-8. https://doi.org/10.2116/analsci.20.1247
Sato, Katsuhiko, et al. "Sugar-sensitive thin films composed of concanavalin A and glycogen." Analytical sciences : the international journal of the Japan Society for Analytical Chemistry vol. 20,9 (2004): 1247-8. doi: https://doi.org/10.2116/analsci.20.1247
Sato K, Imoto Y, Sugama J, Seki S, Inoue H, Odagiri T, Anzai J. Sugar-sensitive thin films composed of concanavalin A and glycogen. Anal Sci. 2004 Sep;20(9):1247-8. doi: 10.2116/analsci.20.1247. PMID: 15478330.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 339 entries